Entrada Therapeutics Inc

TRDA

NASDAQ

Biotechnology

$7.46

USD

+0.01 (+0.13%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $290.08M

Volume 238.0K

Overview Charts Financials Peers Filings & News Analyst Ratings Technical Analysis

Peer Comparison Table

(1/4)
	ALXO	ALX Oncology Holdings Inc	$284.85M	-	-	-
	ELDN	Eledon Pharmaceuticals Inc	$284.05M	-	-	-
	TRDA	Entrada Therapeutics Inc	$270.61M	-	-94.1%	-
	RNAC	Cartesian Therapeutics Inc	$262.01M	-	-94.9%	-
	MGNX	MacroGenics Inc	$256.80M	-	+2.0%	-
	AKBA	Akebia Therapeutics Inc	$252.14M	-	+7.5%	-
	ZSQR	Z Squared Inc (Delaware)	$215.68M	-	+2149.0%	-

Top Peer by Growth

Z Squared Inc (Delaware)

+2149.0% YoY Revenue

Best 1-Year Return

ALX Oncology Holdings Inc

+226.8% Return